By Jan K. Seigel | Published December 3, 2012 | Posted in Pharmaceutical Injuries | Tagged Tags: dangerous drugs, defective product, pharmaceutical companies | Leave a comment
The Food and Drug Administration (FDA) recently announced a recall involving atorvastatin, the generic version of the popular cholesterol reducing drug, Lipitor. According to a number of news reports, the drug was being recalled after some pills contained glass particles. The drug’s maker, Ranbaxy announced that it will stop producing atorvastatin while it completes an Read More
Read More